You need to be logged in to view this video
Discovering and Developing Transformative Therapies to Eliminate Overdose-Related Deaths
CounterX Therapeutics is at the forefront of the battle against the opioid epidemic, exploiting cutting-edge biotechnology to develop life-saving therapeutics and vaccines. We combine scientific expertise with an experienced leadership team and a deep commitment to social impact. Our groundbreaking antibody therapies are designed to blunt the effects of opioids, reduce the risk of overdose, and provide a path to recovery. Additionally, our pioneering vaccine technology aims to prevent addiction relapse by blocking the euphoric effects of opioids and empowering individuals to maintain a long-term recovery.
Biotechnology entrepreneur and executive, Dr. Shawn Iadonato, has a distinguished career as a founder and C-level executive (CEO, COO, CSO) for both public and private biotech companies. He has extensive experience in founding, funding, and building innovative businesses with groundbreaking technologies.
